Stay updated on Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial page.

Latest updates to the Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study record's revision history now shows a new latest revision tag v3.5.3 added and the previous v3.5.2 entry removed.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe History section now shows Revision: v3.5.2 and removes Revision: v3.5.0.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision history now includes v3.5.0 and removes v3.4.3.SummaryDifference0.1%

- Check58 days agoChange DetectedThe revision history now shows Revision: v3.4.3 as the latest version and removes Revision: v3.4.2 from the history.SummaryDifference0.1%

- Check87 days agoChange DetectedAdded a new revision label (v3.4.2) to the record history. Removed a government funding notice and the earlier revision (v3.4.1).SummaryDifference0.6%

- Check94 days agoChange DetectedA site-wide notice about government funding and operating status was added, and the page now shows Revision: v3.4.1; the previous Revision: v3.4.0 was removed.SummaryDifference0.6%

Stay in the know with updates to Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial page.